Oncologix Tech Acquires Angels of Mercy; Gains Leading Healthcare Service Company
05 Agosto 2013 - 6:00PM
Marketwired
Oncologix Tech Inc. (OTCQB: OCLG), announced today the Company has
purchased 100% of the common stock of Angels of Mercy, Inc., a
leader in the Personal Care Attendant (PCA) healthcare services
industry.
Wayne Erwin, OCLG's Chief Executive Officer, remarked,
"Oncologix is extremely delighted to complete the acquisition of
Angels of Mercy. Angels is the leading healthcare services company
in the State of Louisiana providing PCA services to over 200 active
clients, with 168 employees and $2.9 million in annual revenues.
The acquisition establishes the foundation for our healthcare
services division and confirms the strategic mission of the
company: to acquire medical device and healthcare services-related
companies."
Angels of Mercy began its healthcare service operations in 2001
with offices in Alexandria and Lafayette, Louisiana. As a
healthcare service provider, Angels of Mercy delivers education and
training to Personal Care Assistants who provide routine health and
personal care support and assistance with Activities of Daily
Living (ADL) to patients with physical impairments or disabilities
in private homes, nursing care facilities, and other residential
settings. Angels of Mercy holds both PCA-Medicaid Waiver Provider
and Residential Rehabilitation/Supervised Independent Living (SIL)
licenses issued by the Division of Licensing and Certification of
the Department of Social Services and the Louisiana Department of
Health and Hospitals. Licenses are issued to Angels of Mercy for
Region 4 and Region 6 covering 12 parishes within the State of
Louisiana.
Oncologix is an acquisitive diversified medical device and
healthcare holding company. For its customers, Oncologix provides
FDA approved medical devices and state licensed healthcare
services. For its shareholders, Oncologix acquires profitable
operations that build, maintain and nourish shareholder value. The
Company's corporate mission is to be the best small cap medical
device and healthcare holding company in North America.
This press release may contain forward-looking statements, made
in reliance upon Section 21D of the Exchange Act of 1934, which
involve known and unknown risks, uncertainties or other factors
that could cause actual results to differ materially from the
results, performance, or expectations implied by these
forward-looking statements. The Company's expectations, among other
things, are dependent upon economic conditions, continued demand
for its products, the availability of raw materials, retention of
its key management and operating personnel, its ability to operate
its subsidiary companies effectively, need for and availability of
more capital as well as other uncontrollable or unknown factors
which are more fully disclosed in the Company's 8-K on file with
the Securities and Exchange Commission.
Add to Digg Bookmark with del.icio.us Add to Newsvine
CONTACT INFORMATION Wayne Erwin CEO Email Contact
318-451-9543 Investor Relations: Jack Eversull President The
Eversull Group, Inc. 972-571-1624 214-469-2361 fax Email
Contact
Grafico Azioni Oncologix Tech (CE) (USOTC:OCLG)
Storico
Da Dic 2024 a Gen 2025
Grafico Azioni Oncologix Tech (CE) (USOTC:OCLG)
Storico
Da Gen 2024 a Gen 2025